Ligand Pharmaceuticals (LGND) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

LGND is expected to report earnings to fall 6.43% to $1.31 per share on November 05

Ligand Pharmaceuticals LGND Stock Earnings Reports

Q3'24

Est.

$1.31

Q2'24

Beat

by $0.34

Q1'24

Beat

by $0.36

Q4'23

Beat

by $0.39

Q3'23

Beat

by $0.40

The last earnings report on August 06 showed earnings per share of $1.40, beating the estimate of $1.06. With 64.47K shares outstanding, the current market capitalization sits at 1.85B.

View a ticker or compare two or three

Compare

LGND

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LGND
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for LGND (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

555 Heritage Drive

Phone

+1 858 550-7500

Employees

Web

https://www.ligand.com